Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hester Biosciences Limited ( (IN:HESTERBIO) ) has issued an update.
Hester Biosciences Limited has announced the closure of its trading window for dealings in the company’s equity shares from 1 January 2026 until 48 hours after its financial results for the quarter and nine-month period ended 31 December 2025 are made publicly available. The move, undertaken in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct for directors, promoters, designated employees, and connected persons, is a standard governance measure aimed at preventing insider trading and reinforcing regulatory compliance and transparency for investors and other stakeholders.
More about Hester Biosciences Limited
Hester Biosciences Limited is an Indian biosciences company listed on BSE and NSE, operating in the pharmaceutical and life sciences sector with a focus on vaccines and animal healthcare products. Its equity shares are traded under the scrip code 524669 on BSE and the symbol HESTERBIO on NSE, reflecting its presence in the public capital markets and regulatory oversight environment.
Average Trading Volume: 328
Technical Sentiment Signal: Sell
Current Market Cap: 13.47B INR
For an in-depth examination of HESTERBIO stock, go to TipRanks’ Overview page.